<!DOCTYPE html>
<html lang="en" style="background-image: url(/chem/Images/trip.jpg); padding: 20px;">
<head>
  <!--Matteo Etchart, 2022 -->
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="/chem/styles/styles.css">
    <title>Matteo Inquiry</title>
    <link rel="icon" href="/chem/Images/mario_PNG75.png">
    </head>
<body>
  <div style="text-align: center; padding-top: 20px;"><a href="/Index.html"><img src="/chem/Images/Gymnopilus_luteoviridis.jpg" height="200px" width="200px" alt="Zapiak Bat"></a></div>
    <h1>Psilocybin and the affects on the human brain:</h1>
    
    <h2 class="inlineCaca">Welcome DeWynter</h2>
    <p class="inlineCaca"> Mushrooms are Lorem ipsum dolor sit amet consectetur adipisicing elit. Qui vero aspernatur quisquam officiis, sint reiciendis nihil. <br>Autem esse architecto adipisci cum, laborum, sint vel nulla eaque quisquam tempore odit repellendus?</p>
    <nav>
        <div class = "something ">
        <button><a href="Index.html">Home</a></button>
        <button><a href="Abstract.html">Abstract</a></button>
        <button><a href="Disscussion.html">Disscussion</a></button>
        <button><a href="Welcome.html">References</a></button>
          </div>
          <!--make this pop out wit Javascript --> 
    <img style="float: left; border-radius: 15px 50px 30px 5px; " src="/chem/Images/221101-psilocybin-magic-mushrooms-mn-0953-3bb7b9.jpg" height="200px" width="400px"><img src="/chem/Images/markonfire_a_man_in_a_science_lab_producing_synthetic_psychedel.png" height="200px" width="400px" style="float: right; border-radius: 15px;"><p style= "margin-left: 450px; margin-right: 450px; text-align: left; font-size: 18px; "> 	&#2 <b>Abstract:</b>
      Psilocybin, also known as "the magic mushroom", is a naturally occurring psychedelic substance that has been used for centuries for its mind-altering effects. Recent scientific studies have shown that psilocybin has a profound effect on the human brain, specifically in the areas related to consciousness, perception, and emotion. This report aims to provide an overview of the current understanding of how psilocybin affects the human brain, as well as its potential therapeutic benefits for mental health conditions.
      <br>
      <br>
      </p><img src="/chem/Images/pexels-egor-kamelev-1685650.jpg"  height="550px" width="400px" style="float: left; padding-top: 5px; border-radius: 15px 50px 30px 5px; "><img src="/chem/Images/Psilocybin.width-1524.jpg"  height="250px" width="400px" style="float: right; padding-top: 5px; border-radius: 15px;"></p><p style= "margin-left: 450px; margin-right: 450px; text-align: left; font-size: 18px;">
      &#2 <b>Discussion:</b>
      Psilocybin is a naturally occurring psychedelic substance found in over 200 species of mushrooms. It has a long history of use in traditional indigenous cultures for religious and spiritual practices. The active ingredient in magic mushrooms is psilocybin. Psilocybin is a tryptamine compound that is structurally similar to serotonin, a neurotransmitter that plays an important role in regulating mood, anxiety, and other cognitive processes. Psilocybin is converted to psilocin in the body, which is responsible for the psychoactive effects of the drug.

      When consumed, psilocybin is rapidly absorbed in the stomach and small intestine and is then transported to the liver, where it is metabolized into psilocin. Psilocin then diffuses across the blood-brain barrier and binds to serotonin receptors in the brain. This binding leads to an increase in the activity of the neurotransmitters serotonin and glutamate, which in turn leads to changes in perception, thought, and emotion. </p><img src="/chem/Images/pexels-pixabay-247409.jpg"  height="280px" width="400px" style="float: right; padding-top: 0px; border-radius: 15px 50px 30px 5px; ">
      <p style= "margin-left: 450px; margin-right: 450px; text-align: left; font-size: 18px;">
      
      One of the main ways in which psilocybin affects the brain is by increasing activity in the default mode network (DMN), a network of brain regions that is active during introspection and self-reflection. This increased activity in the DMN is thought to be responsible for the feelings of euphoria and connectedness that users often experience while under the influence of psilocybin.
      
      Psilocybin also affects the brain by increasing the levels of serotonin, a neurotransmitter that is responsible for regulating mood, appetite, and sleep. This increase in serotonin levels is thought to be responsible for the feelings of euphoria and well-being that users often experience while under the influence of psilocybin. Additionally, psilocybin has been found to increase the levels of the neurotransmitter glutamate, which is responsible for memory and learning.
      
      The effects of psilocybin can be divided into two main categories: positive and negative. Positive effects include changes in perception, such as visual hallucinations and synesthesia, changes in thought, such as increased creativity and a sense of interconnectedness, and changes in emotion, such as euphoria and a sense of transcendence. Negative effects include anxiety, paranoia, and confusion.</p><img src="/chem/Images/blue-meanie-milk-chocolate-front-scaled-1.jpg"  height="280px" width="400px" style="float: right; padding-top: 0px; border-radius: 15px 50px 30px 5px;">
      <p style= "margin-left: 450px; margin-right: 450px; text-align: left; font-size: 18px;">
      Recent research has also shown that psilocybin may have therapeutic benefits for a wide range of mental health conditions such as depression, anxiety, and PTSD. In a study published in the Journal of Psychopharmacology, patients suffering from treatment-resistant depression showed significant improvements in their symptoms after receiving a single dose of psilocybin. Another study published in the Journal of Clinical Psychiatry found that psilocybin therapy significantly reduced symptoms of anxiety and depression in patients with advanced-stage cancer.
      
      Psilocybin therapy has also been found to be an effective treatment for addiction. In a study published in the Journal of Psychopharmacology, patients who received psilocybin therapy for their addiction showed significant reductions in their drug use and increased rates of abstinence compared to those who received traditional therapy.</p><img src="/chem/Images/pexels-david-waschbüsch-8843375.jpg"  height="480px" width="400px" style="float: left; padding-top: 0px; border-radius: 15px 50px 30px 5px;">
      <p style= "margin-left: 450px; margin-right: 450px; text-align: left; font-size: 18px;">
      
      It is important to note that more research is needed to fully understand the therapeutic potential of psilocybin. However, the current research suggests that psilocybin has the potential to be a valuable addition to the treatment options available for mental health conditions. It is also important to note that psilocybin can have negative effects, particularly in high doses, and that it should only be used under the supervision of a healthcare professional.al health conditions such as depression, anxiety, and PTSD. In a study published in the Journal of Psychopharmacology, patients suffering from treatment-resistant depression showed significant improvements in their symptoms after receiving a single dose of psilocybin. Another study published in the Journal of Clinical Psychiatry found that psilocybin therapy significantly reduced symptoms of anxiety and depression in patients with advanced-stage cancer.
      <br>
      <br>
      &#2 <b>Conclusion:</b>
      Psilocybin has been shown to have a profound effect on the human brain, specifically in the areas related to consciousness, perception, and emotion. Psilocybin has been found to have therapeutic benefits for a wide range of mental health conditions such as depression, anxiety, and PTSD. Psilocybin therapy has also been found to be an effective treatment for addiction. It is important to note that more research is needed to fully understand the therapeutic potential of psilocybin. However, the current research suggests that psilocybin has the potential to be a valuable addition to the treatment options available for mental health conditions.
      <br>
      <br>
      &#2 <b>Sources:</b><br>
      
      Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., ... & Nutt, D. J. (2016). Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Scientific reports, 6, 1-12.<br>
      <a href="https://www.canada.ca/en/health-canada/services/substance-use/controlled-illegal-drugs/magic-mushrooms.html"> https://www.canada.ca/en/health-canada/services/substance-use/controlled-illegal-drugs/magic-mushrooms.html</a><br>

      Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., ... & Sussman, N. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of psychopharmacology, 30(12), 1165-1180.<br>
      <a href="https://pubchem.ncbi.nlm.nih.gov/compound/Psilocybine"> https://pubchem.ncbi.nlm.nih.gov/compound/Psilocybine</a><br>
      Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P. C., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. Journal of psychopharmacology, 29(3), 289-299.<br>
      <a href="https://ici.radio-canada.ca/reportage-photo/2543/champignon-depression-psilocybine-microdose-medicament-hallucinogene-champis"> https://ici.radio-canada.ca/reportage-photo/2543/champignon-depression-psilocybine-microdose-medicament-hallucinogene-champis</a><br>
      Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of psychopharmacology, 28(11), 983-992.<br>
      <a href="https://www.medicalnewstoday.com/articles/308850"> https://www.medicalnewstoday.com/articles/308850</a><br>
      Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., ... & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of psychopharmacology, 30(12), 1181-1197.<br>
      <a href="https://www.britannica.com/science/psilocybin"> https://www.britannica.com/science/psilocybin</a><br>
      Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., ... & Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry, 3(7), 619-627.<br>
      <a href="https://en.wikipedia.org/wiki/Psilocybin"> https://en.wikipedia.org/wiki/Psilocybin</a><br>
      Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., ... & Nutt, D. J. (2016). The effects of psilocybin on personality structure. Acta psychiatrica Scandinavica, 134(1), 30-38.<br>
      <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156539/"> https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156539/</a><br>
      Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of psychopharmacology, 28(11), 983-992.<br>
      <a href="https://www.britannica.com/science/psilocybin"> https://www.britannica.com/science/psilocybin</a><br>
      
      
      </p>
    <img src="/chem/Images/pexels-david-waschbüsch-8843375.jpg" height="1000px" width="1000px">
    </nav>
    </body>
</html>